CORRECTED: FTC OKs Quest's $740M Buyout Of Athena

Law360, New York (March 28, 2011, 2:39 PM EDT) -- The Federal Trade Commission on Thursday approved Quest Diagnostics Inc.’s $740 million acquisition of Athena Diagnostics Inc. from Thermo Fisher Scientific Inc.

The FTC granted Quest’s bid for an early termination of the premerger review, finding that the deal, which provides Quest with a leading laboratory specializing in genetic testing for neurological disorders, poses no threat to competition.

Quest announced the deal Feb. 24, offering Thermo Fisher Scientific $740 million in cash for Athena, the leading provider of advanced diagnostic tests used to rule out or...
To view the full article, register now.